Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain

Summary

This research study because is looking at woman with symptoms of chronic pelvic pain caused by short, tight, and tender pelvic floor muscles (Myofascial Pelvic Pain syndrome). The purpose of this study is to determine whether or not injections with onabotulinumtoxinA (Botox) improve symptoms of pain and tenderness. The drug being studied, Botox is FDA approved for other uses. However, Botox is not FDA approved for the use in myofascial pelvic pain (MPP). Therefore, Botox is considered experimental or research in this study.

Timeline

Start

2014-08-01

Primary completion

2015-09-01

Completion

2016-09-01

Drugs

Indications